Drug Labeling

"Drug Labeling" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.

Descriptor ID	D004348
MeSH Number(s)	E05.916.310 J01.576.655.750.321.400 J01.576.761.300.400
Concept/Terms	Drug Labeling Drug Labeling Labeling, Drug Drug Labelling Labelling, Drug Package Inserts, Drug Drug Package Insert Drug Package Inserts Insert, Drug Package Inserts, Drug Package Package Insert, Drug Product Labeling, Drug Drug Product Labeling Labeling, Drug Product Black Box Warning Black Box Warning Black Box Warnings Box Warning, Black Box Warnings, Black Warning, Black Box Warnings, Black Box Boxed Warning Boxed Warnings Warning, Boxed Warnings, Boxed

Below are MeSH descriptors whose meaning is more general than "Drug Labeling".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Technology, Pharmaceutical [E05.916]
Drug Labeling [E05.916.310]
Technology, Industry, Agriculture [J]
Technology, Industry, and Agriculture [J01]
Industry [J01.576]
Manufacturing Industry [J01.576.655]
Drug Industry [J01.576.655.750]
Drug Packaging [J01.576.655.750.321]
Drug Labeling [J01.576.655.750.321.400]
Product Packaging [J01.576.761]
Drug Packaging [J01.576.761.300]
Drug Labeling [J01.576.761.300.400]

Below are MeSH descriptors whose meaning is related to "Drug Labeling".

Below are MeSH descriptors whose meaning is more specific than "Drug Labeling".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Labeling" by people in this website by year, and whether "Drug Labeling" was a major or minor topic of these publications.

Bar chart showing 21 publications over 15 distinct years, with a maximum of 3 publications in 2010 and 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2002	1	0	1
2003	0	1	1
2005	1	0	1
2006	1	0	1
2008	1	1	2
2010	3	0	3
2011	1	1	2
2012	1	0	1
2013	1	0	1
2014	2	1	3
2015	1	0	1
2017	0	1	1
2018	1	0	1
2020	1	0	1

Below are the most recent publications written about "Drug Labeling" by people in Profiles.

Krishnamoorthy V, Ellis AR, McLean DJ, Stefan MS, Nathanson BH, Cobert J, Lindenauer PK, Brookhart MA, Ohnuma T, Raghunathan K. Bleeding After Musculoskeletal Surgery in Hospitals That Switched From Hydroxyethyl Starch to Albumin Following a Food and Drug Administration Warning. Anesth Analg. 2020 10; 131(4):1193-1200.

View in: PubMed
Prado G, Svoboda RM, Teplitz RW, Farberg AS, Rigel DS. Patient knowledge of FDA-mandated sunscreen labeling terminology: A cross-sectional survey. Photodermatol Photoimmunol Photomed. 2019 May; 35(3):141-147.

View in: PubMed
Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, Liu M, Cohen H, George EL, Pohlman AS, Agarwal S, Henneman EA, Bejian SM, Berenholtz SM, Pepin JL, Scanlon MC, Smith BS. Clinical Practice Guideline: Safe Medication Use in the ICU. Crit Care Med. 2017 Sep; 45(9):e877-e915.

View in: PubMed
Psotka MA, von Maltzahn R, Anatchkova M, Agodoa I, Chau D, Malik FI, Patrick DL, Spertus JA, Wiklund I, Teerlink JR. Patient-Reported Outcomes in Chronic?Heart Failure: Applicability for Regulatory Approval. JACC Heart Fail. 2016 10; 4(10):791-804.

View in: PubMed
Shah YD, Singh K, Friedman D, Devinsky O, Kothare SV. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience. Epilepsy Behav. 2016 Mar; 56:50-3.

View in: PubMed
Fantasia HC, Harris AL. Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs. Nurs Womens Health. 2015 Jun-Jul; 19(3):266-70.

View in: PubMed
Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, Simon G, Ahmedani BK, Clarke G, Hunkeler EM, Waitzfelder B, Owen-Smith A, Raebel MA, Rossom R, Coleman KJ, Copeland LA, Soumerai SB. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ. 2014 Jun 18; 348:g3596.

View in: PubMed
Kam-Hansen S, Jakubowski M, Kelley JM, Kirsch I, Hoaglin DC, Kaptchuk TJ, Burstein R. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med. 2014 Jan 08; 6(218):218ra5.

View in: PubMed
Briesacher BA, Soumerai SB, Zhang F, Toh S, Andrade SE, Wagner JL, Shoaibi A, Gurwitz JH. Response to the letter by Mol. Pharmacoepidemiol Drug Saf. 2014 Jan; 23(1):106.

View in: PubMed
Briesacher BA, Soumerai SB, Zhang F, Toh S, Andrade SE, Wagner JL, Shoaibi A, Gurwitz JH. A critical review of methods to evaluate the impact of FDA regulatory actions. Pharmacoepidemiol Drug Saf. 2013 Sep; 22(9):986-94.

View in: PubMed

People

Explore

Similar Concepts

Top Journals